Clinton Group Inc. Trims Holdings in UnitedHealth Group Incorporated (UNH)
Clinton Group Inc. lowered its position in UnitedHealth Group Incorporated (NYSE:UNH) by 93.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,459 shares of the healthcare conglomerate’s stock after selling 52,558 shares during the quarter. Clinton Group Inc.’s holdings in UnitedHealth Group were worth $641,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also recently modified their holdings of UNH. Blue Chip Partners Inc. acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $110,000. Bruderman Asset Management LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. increased its holdings in shares of UnitedHealth Group by 433.3% in the second quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock valued at $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC acquired a new position in shares of UnitedHealth Group in the second quarter valued at approximately $121,000. Finally, Kings Point Capital Management increased its holdings in shares of UnitedHealth Group by 27.9% in the first quarter. Kings Point Capital Management now owns 687 shares of the healthcare conglomerate’s stock valued at $113,000 after purchasing an additional 150 shares during the period. Institutional investors own 86.20% of the company’s stock.
UnitedHealth Group Incorporated (NYSE UNH) traded down $0.15 on Thursday, reaching $219.94. The company’s stock had a trading volume of 2,397,400 shares, compared to its average volume of 3,116,121. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $213,282.06, a P/E ratio of 22.93, a price-to-earnings-growth ratio of 1.63 and a beta of 0.66. UnitedHealth Group Incorporated has a one year low of $156.09 and a one year high of $231.77.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date of this dividend is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s payout ratio is 33.26%.
In other news, Director Gail R. Wilensky sold 5,600 shares of the company’s stock in a transaction on Wednesday, November 29th. The stock was sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares in the company, valued at $13,652,503.47. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michele J. Hooper sold 5,000 shares of the company’s stock in a transaction on Monday, December 4th. The shares were sold at an average price of $222.20, for a total value of $1,111,000.00. Following the completion of the sale, the director now owns 36,989 shares in the company, valued at $8,218,955.80. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 62,606 shares of company stock worth $12,677,525. 0.89% of the stock is owned by company insiders.
A number of research analysts have recently issued reports on UNH shares. Zacks Investment Research lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. Cantor Fitzgerald reissued a “buy” rating and issued a $225.00 target price on shares of UnitedHealth Group in a report on Monday, November 27th. ValuEngine lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 5th. Piper Jaffray Companies upped their price objective on UnitedHealth Group to $228.00 and gave the stock an “overweight” rating in a report on Tuesday, October 17th. Finally, Morgan Stanley upped their price objective on UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a report on Thursday, August 17th. Three equities research analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $224.56.
UnitedHealth Group Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Stock Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related stocks with our FREE daily email newsletter.